Medical Weight Loss for Palm Coast, Florida Residents

Palm Coast, Florida residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Palm Coast through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Palm Coast: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Florida. Results vary. Doctor review just $119 (medication separate).

Why Palm Coast Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Palm Coast a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Florida. That is the entire promise, and we keep it.

Palm Coast is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Palm Coast patients at home.

Our clinic sits in Costa Mesa, California, but if you live in Palm Coast, Florida, you receive the exact same physician-supervised care from Dr. Anjmun Sharma over telehealth, with no drive and no waiting room. We care for patients throughout Palm Coast and the greater Flagler County area. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Palm Coast.

Distance simply stops mattering here, since every appointment for Palm Coast residents takes place over secure video rather than in a waiting room. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. Florida is one of the most populous states in the nation, and New Hope Weight Loss serves patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Palm Coast patients.

How Telehealth Works for Palm Coast

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Palm Coast. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Palm Coast address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Palm Coast

How does someone in Palm Coast access New Hope Weight Loss?

Access from Palm Coast is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Palm Coast, Florida through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Palm Coast residents?

A clinic visit is never part of it for Palm Coast. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Palm Coast inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Palm Coast patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Palm Coast residents are charged no distance surcharge.

What areas of Palm Coast do you serve?

We serve patients from across Palm Coast by telehealth, including Palm Coast and the greater Flagler County area.

Is bilingual (Spanish) telehealth care available for Palm Coast patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Palm Coast patients.

Palm Coast Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Palm Coast, Florida by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.